Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Dr. Reddy’s Warns Over Currency Effects As Emerging Markets Slide

This article was originally published in PharmAsia News

Executive Summary

Indian generic drug giant Dr. Reddy’s says the crash of currencies in some emerging markets may impact earnings as it reported a tough third-quarter in which net profit was sharply below market expectations.

Advertisement

Related Content

Dr Reddy's Proprietary Products Gain US Traction Amid Tough Q2

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

SC089283

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel